James Murrough, MD
Director, Depression and Anxiety Center
The Mount Sinai Hospital
Associate Professor, Psychiatry, and Neuroscience
Icahn School of Medicine at Mount Sinai
Related Videos
Video
From Party to Prescription: How Psychedelics Are Changing Traditional Psychiatry
Listen as Mount Sinai neuroscientists discuss ketamine, cannabis, and ecstasy as potential treatments for treatment-resistant depression, opioid addiction, and post-traumatic stress disorder
Video
New Frontiers for Depression: Deep Brain Stimulation, Esketamine, and the Immune System
“In five years, we expect to have a range of new treatments available targeting people with different forms of depression that work effectively, specifically for them.” –Eric Nestler, MD, PhD